Beshear Prohibits Nationally Targeted Drug in Kentucky

Kentucky Takes Immediate Action Against "Designer Xanax"

In response to a growing public health crisis, Kentucky Governor Andy Beshear has taken emergency measures to ban the sale of “designer Xanax,” a synthetic drug linked to numerous overdose deaths. This move follows a request from the state’s attorney general, who is leading efforts to combat the potent substance that has become a major concern across the state and beyond.

The decision by Beshear comes as part of a broader initiative involving 21 attorneys general from various states. Led by Kentucky Attorney General Russell Coleman, this coalition is urging the U.S. Drug Enforcement Administration (DEA) to take emergency action against the unregulated drug. They argue that bromazolam, commonly referred to as “designer Xanax,” poses a significant threat to public health and is increasingly contributing to fatal overdoses.

Coleman, a Republican, emphasized the urgent need for law enforcement to have the tools necessary to address this dangerous drug. He stated in a news release that the current situation requires immediate and decisive action to protect communities from the harmful effects of this substance.

The Impact of Bromazolam

Bromazolam, which is being sold as counterfeit prescription pills, has been classified as a Schedule I controlled substance in Kentucky following Beshear's emergency regulation. This classification allows law enforcement to make arrests for selling or possessing the drug. The governor's office highlighted that this step provides critical resources to combat the spread of this deadly substance.

Coleman warned that bromazolam is often misrepresented as benzodiazepines, medications typically used to treat anxiety disorders, insomnia, and seizures. However, unlike regulated medications, illicitly manufactured bromazolam lacks quality controls, making it particularly hazardous for users.

Beshear, a former Kentucky attorney general currently serving his second term as governor, is seen as a potential candidate for president in 2028. His actions on this issue reflect a commitment to addressing the opioid and synthetic drug crisis that continues to impact communities across the nation.

A Growing National Crisis

According to Beshear's office, bromazolam was involved in nearly 50 overdose deaths in Kentucky last year alone. The drug's potency and unpredictability make it especially dangerous when combined with opioids or other central nervous system depressants. The attorneys general highlighted that the lack of federal scheduling for bromazolam creates significant challenges for law enforcement and public health officials trying to respond to this emerging crisis.

In their letter to DEA Administrator Terry Cole, the attorneys general expressed concern over the continued distribution of bromazolam through illicit channels. They argued that emergency action by the DEA would help remove the drug from circulation, enable prosecutors to hold traffickers accountable, and send a clear message that such substances have no place in communities.

Coalition Efforts

The request to the DEA includes support from attorneys general across multiple states, including Alabama, Arkansas, Florida, Georgia, Indiana, Iowa, Louisiana, Mississippi, Montana, Nebraska, North Dakota, Ohio, Oklahoma, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Virginia, and West Virginia. This broad coalition underscores the widespread concern about the dangers posed by bromazolam and the need for coordinated action at both the state and federal levels.

Coleman expressed gratitude for the collaboration between state officials and emphasized the importance of working together to tackle this grave threat. He noted that even a single pill can be lethal, and the ongoing efforts are crucial to protecting lives and ensuring safer communities.

By taking swift action, Kentucky is setting an example for other states facing similar challenges. The focus remains on reducing the availability of dangerous synthetic drugs and providing law enforcement with the necessary tools to combat this growing public health crisis.